Tetsu Hayashida

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Topics

Multidrug Resistant

Metastatic Breast Cancer

Top Venues

Cancer research

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Takehiro Yamamoto, Tetsu Hayashida, Yohei Masugi, Kiyotaka Oshikawa, Noriyo Hayakawa, Mai Itoh, Chiyoko Nishime, Masami Suzuki, Aiko Nagayama, Yuko Kawai, Takako Hishiki, Tomomi Matsuura, Yoshiko Naito, Akiko Kubo, Arisa Yamamoto, Yujiro Yoshioka, Tomokazu Kurahori, Misa Nagasaka, Minako Takizawa, Naoharu Takano, Koji Kawakami, Michiie Sakamoto, Masatoshi Wakui, Takushi Yamamoto, Yuko Kitagawa, Yasuaki Kabe, Kenichi Horisawa, Atsushi Suzuki, Masaki Matsumoto, Makoto Suematsu
PRMT1 Sustains De Novo Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer. Cancer research 84 (7) (2024)
Takehiro Yamamoto, Tetsu Hayashida, Yohei Masugi, Kiyotaka Oshikawa, Noriyo Hayakawa, Mai Itoh, Chiyoko Nishime, Masami Suzuki, Aiko Nagayama, Yuko Kawai, Takako Hishiki, Tomomi Matsuura, Yoshiko Naito, Akiko Kubo, Arisa Yamamoto, Yujiro Yoshioka, Tomokazu Kurahori, Misa Nagasaka, Minako Takizawa, Naoharu Takano, Koji Kawakami, Michiie Sakamoto, Masatoshi Wakui, Takushi Yamamoto, Yuko Kitagawa, Yasuaki Kabe, Kenichi Horisawa, Atsushi Suzuki, Masaki Matsumoto, Makoto Suematsu
PRMT1 sustains de novo fatty acid synthesis by methylating PHGDH to drive chemoresistance in triple-negative breast cancer. Cancer research (2024)
Tetsu Hayashida, Erina Odani, Masayuki Kikuchi, Aiko Nagayama, Tomoko Seki, Maiko Takahashi, Noriyuki Futatsugi, Akiko Matsumoto, Takeshi Murata, Rurina Watanuki, Takamichi Yokoe, Ayako Nakashoji, Hinako Maeda, Tatsuya Onishi, Sota Asaga, Takashi Hojo, Hiromitsu Jinno, Keiichi Sotome, Akira Matsui, Akihiko Suto, Shigeru Imoto, Yuko Kitagawa
Establishment of a deep-learning system to diagnose BI-RADS4a or higher using breast ultrasound for clinical application. Cancer science 113 (10) (2022)
Tetsu Hayashida, Aiko Nagayama, Tomoko Seki, Maiko Takahashi, Akiko Matsumoto, Anna Kubota, Hiromitsu Jinno, Hiroaki Miyata, Yuko Kitagawa
Feasibility study on collecting patient-reported outcomes from breast cancer patients using the LINE-ePRO system. Cancer science 113 (5) (2022)
Xiaozhong Teng, Tetsu Hayashida, Takeshi Murata, Aiko Nagayama, Tomoko Seki, Maiko Takahashi, Yuko Kitagawa
A transposon screen identifies enhancement of NF-κB pathway as a mechanism of resistance to eribulin. Breast cancer (Tokyo, Japan) 28 (4) (2021)
Kuniko Sunami, Hideaki Bando, Yasushi Yatabe, Yoichi Naito, Hideaki Takahashi, Katsuya Tsuchihara, Shinichi Toyooka, Koshi Mimori, Shinji Kohsaka, Hiroyuki Uetake, Ichiro Kinoshita, Keigo Komine, Masayuki Takeda, Tetsu Hayashida, Kenji Tamura, Kazuto Nishio, Noboru Yamamoto, null null
Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNA. Cancer science 112 (9) (2021)
Ayako Nakashoji, Tetsu Hayashida, Shigeo Yamaguchi, Yuko Kawai, Masayuki Kikuchi, Takamichi Yokoe, Aiko Nagayama, Tomoko Seki, Maiko Takahashi, Yuko Kitagawa
Comprehensive analysis of the homeobox family genes in breast cancer demonstrates their similar roles in cancer and development. Breast cancer research and treatment 186 (2) (2021)
Ayako Nakashoji, Tetsu Hayashida, Yuko Kawai, Masayuki Kikuchi, Rurina Watanuki, Takamichi Yokoe, Tomoko Seki, Maiko Takahashi, Kazuhiro Miyao, Shigeo Yamaguchi, Yuko Kitagawa
Identification of a Modified HOXB9 mRNA in Breast Cancer. Journal of oncology 2020 (2020)
Tetsu Hayashida, Hiromitsu Jinno, Katsuaki Mori, Hiroki Sato, Akira Matsui, Takashi Sakurai, Hiroaki Hattori, Shin Takayama, Masahiro Wada, Maiko Takahashi, Hirohito Seki, Tomoko Seki, Aiko Nagayama, Akiko Matsumoto, Yuko Kitagawa
Phase II trial of eribulin mesylate as a first- or second-line treatment for locally advanced or metastatic breast cancer: a multicenter, single-arm trial. BMC cancer 18 (1) (2018)